Skip to content

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00130130
Enrollment
20
Registered
2005-08-15
Start date
2005-08-31
Completion date
2011-12-31
Last updated
2012-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

The overall purpose of this project is to improve nurse skills regarding neuropathic pain (NP) assessment, treatment and referral practices through implementation of an evidence-based algorithm and to improve selected patient outcomes as a result of algorithm use.

Detailed description

Neuropathic pain (NP) is defined as pain that arises from injury, disease or dysfunction of the central or peripheral nervous system. For the patient focused phase of the project NP treatment will be guided via the Peripheral Neuropathy Treatment Algorithm. Patients will receive algorithm-specific treatment for 12 weeks.

Interventions

None listed

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Cancer patients experiencing NP from a variety of causes * NP Visual Analogue Scale (VAS) score equal to or \> 4 with 12 week estimated duration * Karnofsky Performance Status (KPS) 60% or greater * Age greater than 18

Exclusion criteria

* Patients undergoing anticancer or invasive pain procedures specifically intended to palliate NP are ineligible

Design outcomes

Primary

MeasureTime frame
To implement an evidence based screening, assessment, treatment, and referral guideline for hematology/oncology patients with NP receiving careoutcome measures will consist of the NPVAS, and a PPCPS adapted rom the original project. Adequate satisfaction will be defined as 25% or mor of all patients reporting being very or completely satisfied as measured by PPCPS

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026